It’s hard to miss how much pressure there is these days to look a certain way, especially with all those curated lives and personas online. For teenagers, the constant feed of posts showing chiseled jaws, ripped bodies, and impossibly clear skin has morphed into a kind of beauty arms race. Looksmaxxing, which is the idea that you should always be working harder to boost your appearance, is everywhere. And just when you think this trend can’t get any weirder, it’s taken a sharp turn: now, some teenage boys are reaching for a cancer drug, hoping it'll help them grow taller. This latest obsession is called ‘heightmaxxing’. What exactly is it? Hack your way to a few more inches by taking erdafitinib, a medication designed for treating advanced bladder cancer. It sounds wild, but social media communities are pushing it, passing around stories and tips as if height was as easy to order up as a protein shake. Recently, a Rolling Stone report brought attention to this dangerous trend, where teen boys, some as young as 15, are finding ways to buy erdafitinib from overseas, sometimes spending hundreds of dollars a month. They post about their experiences online, sharing supposed gains, but also confessing to gnarly side effects like nosebleeds and joint pain. It’s not just about risking their health; it’s a sign of how intense the pressure has become to fit a digital fantasy of what a young man should look like.

What is heightmaxxing and why are teenage boys doing it?

Heightmaxxing is just the latest spin on looksmaxxing, which is itself a mash-up of online advice about transforming how you look, mostly aimed at young men. Some suggestions are fairly innocent, like trying new haircuts or working out. But as you go deeper down the rabbit hole, you find much more extreme ideas: weird supplements, unregulated steroids, off-the-shelf plastic surgery kits, and now, prescription drugs meant for serious illnesses. Height, for whatever reason, has climbed to the top of the looksmaxxing wish list. Online, there’s always some meme linking being tall to confidence, desirability, and even being seen as more “manly.” If you’re a teenage boy wrestling with the usual puberty insecurities, hearing over and over that “girls only date guys over six feet” digs deep. Suddenly, being five-ten isn’t just about basketball tryouts; it feels like the world’s stacked against you. Take Zak, for example, who’s been featured in the Rolling Stone article. He’s 17 now and lives in New York. He says he started taking erdafitinib off and on at age 15 because he got tired of being shorter than his classmates and fed up with social media jokes about “short kings.” He shelled out around $300 for a month’s supply from some online seller overseas. Even while worrying this was risky (he saved money in case he ended up in the ER), the fear of being “not tall enough” was stronger than the fear of side effects.

Erdafitinib: Inside the cancer drug and how it supposedly helps with height

Erdafitinib is a powerful drug doctors prescribe as a last resort for adults with certain types of aggressive bladder cancer. It’s a tyrosine kinase inhibitor, meaning it blocks FGFR proteins that help cells grow. For cancer patients with very specific genetic changes, it can be a lifesaver. It’s hardcore, approved by the US Food and Drug Administration (FDA) in 2019 for very specific cases. No one intended this drug for teenagers trying to stretch out a growth spurt. The only reason it’s popped up in the looksmaxxing community is that it messes with FGFR3, a protein that also happens to have a role in how bones grow. Bones lengthen at the growth plates during childhood and puberty. Tinker with those growth plates, and maybe, just maybe, you can squeeze out a few more centimeters, even if you’re already past your prime growing years. There is, however, a massive leap from theory to reality. Yes, scientists have noticed that blocking FGFR3 can influence bone growth. But no legitimate study says a healthy teenager should mess with erdafitinib to get taller. Where did this idea even come from? That traces back to a 2024 medical study titled Accelerated Linear Growth during Erdafitinib Treatment: An FGFR-Related, but Growth Factor and Sex Steroid-Independent Mechanism? out of Vienna, where researchers noticed two kids with central nervous system tumors experienced rapid growth after receiving erdafitinib as a compassionate, end-of-the-line treatment. Their bones grew faster, and their growth plates changed. For these two very sick children, and only because all other treatments failed, the result was striking. But that’s where the connection should end. The study was tiny. These kids were already battling serious diseases. And doctors weren’t handing out erdafitinib to see if it’d make healthy kids inch taller. Instead, an internet rumor machine snatched up this tiny glimmer, twisted it around, and made it into a promise: erdafitinib equals height. The real science just isn’t there to back up that claim.

What are the side effects and health risks of taking erdafitinib?

Zak, the teen from New York, talked about daily nosebleeds, skin that peeled and cracked, and intense joint pain so bad he couldn’t even stretch his arms in the morning. That’s actually pretty typical for erdafitinib. The FDA warning label lists possible vision changes, severe diarrhea, mouth ulcers, nail problems, dangerously high phosphate levels in the blood (which can, weirdly enough, cause minerals to build up in your arteries or soft tissues), and in extreme cases, irreversible eye damage. Of course, none of this is surprising when you remember that this drug is designed for adults with life-threatening cancer who’ve run out of safer options. No one’s ever tested what happens when you give it to a healthy, still-growing teenager. There’s no safe way to repurpose this as a DIY height booster. Pediatric hormone specialists and endocrinologists are especially worried. Adalbert Raimann from Vienna points out that no one knows what the long-term effects could actually be if you tamper with bone development in a normal adolescent. Andrew Dauber from Children’s National Hospital in the US echoes the same concern: the risks are unknown, but the logic just isn’t there to justify playing around with growth pathways.

Why is this happening now?

Is looksmaxxing spinning out of control? Well, the reality is that looksmaxxing can be harmless, and sometimes even healthy. Who doesn’t want to look and feel their best? Self-care isn’t a crime. But once it turns into a competition, where the winners are the ones who hit some arbitrary beauty standard, everything gets a lot more toxic. A report by Johns Hopkins in August 2026 warned that boys are under growing pressure thanks to apps that rate their looks, influencers who never seem to have a bad photo, and endless “tips” that sometimes veer into the reckless: crash diets, steroids, and now cancer drugs. It’s easy to see how wanting to feel “normal” online turns into a constant chase for physical upgrades. Heightmaxxing is a warning sign of how far this pressure will push teenagers. When getting taller is less about natural biology and more about risking your health with black-market drugs, it’s clear that social media’s beauty standards are hurting young people in a very real way: making them doubt their worth, sabotage their own health, and gamble with their future. Even when the side effects get ugly, some teens don’t want to quit. Chasing that digital ideal, for some, still feels more urgent than facing the pain.

End of Article